Biotech

Sarepta Therapeutics Inc (NASDAQ:SRPT) shares rose 26.63% on Tuesday to $23.10, returning 1.07% to $23.10 in after-hours trading. Sarepta Therapeutics Inc (NASDAQ:SRPT) shared that the U.S. Food and Drug Administration (FDA) notified the company that it will not be able to complete their work by the Prescription Drug User Fee Act (PDUFA) target date of...

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) just picked up approval for its schizophrenia maintenance candidate. Here's all you need to know about the drug, and what it means for the company going forward. Imagine the trauma of you or a loved one losing touch with reality, feeling paranoid, experiencing auditory, visual,...

Celator Pharmaceuticals Inc (NASDAQ:CPXX) shares surged 71.59% to $30.08 on Tuesday after an acquisition announcement by Jazz Pharmaceuticals. Celator Pharmaceuticals Inc (NASDAQ:CPXX)  is an oncology-focused biopharmaceutical company engaged in developing products to improve patient outcomes in cancer. CombiPlex, its technology platform,  enables the design and evaluation of optimized combinations incorporating traditional...

Minerva Neurosciences Inc (NASDAQ:NERV) shares jumped 13.09% on June 1 to $13.91 after the company shared positive top-line results in clinical trials for its antidepressant drug candidate. Minerva Neurosciences Inc (NASDAQ:NERV) is a clinical-stage biopharmaceutical company that is focused on the development and commercialization of a portfolio of product candidates to treat...

Galena Biopharma Inc (NASDAQ:GALE) shares were up more than 19% on Tuesday to $2.16, nearing the top of its 52-week range at $2.39. Galena Biopharma Inc (NASDAQ:GALE) reported earnings per share of -$0.09 versus analysts estimates at -$0.06 at zero revenues. The company is focused on developing and commercializing targeted oncology...